Xing-wei Wu

Dr. Xing-wei Wu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 June 2021 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
YFYuting Fan
Yuting Fan
ELEnwu Long
Enwu Long
LCLulu Cai
Lulu Cai
QCQiyuan Cao
Qiyuan Cao
XWXing-wei Wu
Xing-wei Wu
RTRong-Sheng Tong
Rong-Sheng Tong
Purpose: The objective of this study was to evaluate the efficacy of machine learning algorithms in predicting risks of complications and poor glycemic control in nonadherent type 2 diabetes (T2D).Materials and Methods: This study was a real-world study of the complications and blood glucose prognosis of nonadherent T2D patients. Data of inpatients in Sichuan Provincial People’s Hospital from January 2010 to December 2015 were collected. The T2D patients who had neither been monitored for glycosylated hemoglobin A nor had changed their hyperglycemia treatment regimens within the last 12 months were the object of this study. Seven types of machine learning algorithms were used to develop 18 prediction models. The predictive performance was mainly assessed using the area under the curve of the testing set.Results: Of 800 T2D patients, 165 (20.6%) met the inclusion criteria, of which 129 (78.2%) had poor glycemic control (defined as glycosylated hemoglobin A ≥7%). The highest area under the curves of the testing set for diabetic nephropathy, diabetic peripheral neuropathy, diabetic angiopathy, diabetic eye disease, and glycosylated hemoglobin A were 0.902 ± 0.040, 0.859 ± 0.050, 0.889 ± 0.059, 0.832 ± 0.086, and 0.825 ± 0.092, respectively.Conclusion: Both univariate analysis and machine learning methods reached the same conclusion. The duration of T2D and the duration of unadjusted hypoglycemic treatment were the key risk factors of diabetic complications, and the number of hypoglycemic drugs was the key risk factor of glycemic control of nonadherent T2D. This was the first study to use machine learning algorithms to explore the potential adverse outcomes of nonadherent T2D. The performances of the final prediction models we developed were acceptable; our prediction performances outperformed most other previous studies in most evaluation measures. Those models have potential clinical applicability in improving T2D care.

17 November 2022 in Frontiers in Public Health
Verified
Journal Article
Open access
MLMengting Li
Mengting Li
XLXiangyu Lu
Xiangyu Lu
HYHengBo Yang
HengBo Yang
YRYuan Rong
Yuan Rong
YYYong Yang
Yong Yang
XWXing-wei Wu
Xing-wei Wu
Background: Medication adherence is the main determinant of effective management of type 2 diabetes, yet there is no gold standard method available to screen patients with high-risk non-adherence. Developing machine learning models to predict high-risk non-adherence in patients with T2D could optimize management.Methods: This cross-sectional study was carried out on patients with T2D at the Sichuan Provincial People's Hospital from April 2018 to December 2019 who were examined for HbA1c on the day of the survey. Demographic and clinical characteristics were extracted from the questionnaire and electronic medical records. The sample was randomly divided into a training dataset and a test dataset with a radio of 8:2 after data preprocessing. Four imputing methods, five sampling methods, three screening methods, and 18 machine learning algorithms were used to groom data and develop and validate models. Bootstrapping was performed to generate the validation set for external validation and univariate analysis. Models were compared on the basis of predictive performance metrics. Finally, we validated the sample size on the best model.Results: This study included 980 patients with T2D, of whom 184 (18.8%) were defined as medication non-adherence. The results indicated that the model used modified random forest as the imputation method, random under sampler as the sampling method, Boruta as the feature screening method and the ensemble algorithms and had the best performance. The area under the receiver operating characteristic curve (AUC), F1 score, and area under the precision-recall curve (AUPRC) of the best model, among a total of 1,080 trained models, were 0.8369, 0.7912, and 0.9574, respectively. Age, present fasting blood glucose (FBG) values, present HbA1c values, present random blood glucose (RBG) values, and body mass index (BMI) were the most significant contributors associated with risks of medication adherence.Conclusion: We found that machine learning methods could be used to predict the risk of non-adherence in patients with T2D. The proposed model was well performed to identify patients with T2D with non-adherence and could help improve individualized T2D management.

22 April 2024 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
YWYue Wu
Yue Wu
XYXixuan Yu
Xixuan Yu
MLMengting Li
Mengting Li
JZJing Zhu
Jing Zhu
JYJun Yue
Jun Yue
XWXing-wei Wu
Xing-wei Wu
Introduction: It is known that patients with immune-abnormal co-pregnancies are at a higher risk of adverse pregnancy outcomes. Traditional pregnancy risk management systems have poor prediction abilities for adverse pregnancy outcomes in such patients, with many limitations in clinical application. In this study, we will use machine learning to screen high-risk factors for miscarriage and develop a miscarriage risk prediction model for patients with immune-abnormal pregnancies. This model aims to provide an adjunctive tool for the clinical identification of patients at high risk of miscarriage and to allow for active intervention to reduce adverse pregnancy outcomes.Methods: Patients with immune-abnormal pregnancies attending Sichuan Provincial People’s Hospital were collected through electronic medical records (EMR). The data were divided into a training set and a test set in an 8:2 ratio. Comparisons were made to evaluate the performance of traditional pregnancy risk assessment tools for clinical applications. This analysis involved assessing the cost-benefit of clinical treatment, evaluating the model's performance, and determining its economic value. Data sampling methods, feature screening, and machine learning algorithms were utilized to develop predictive models. These models were internally validated using 10-fold cross-validation for the training set and externally validated using bootstrapping for the test set. Model performance was assessed by the area under the characteristic curve (AUC). Based on the best parameters, a predictive model for miscarriage risk was developed, and the SHapley additive expansion (SHAP) method was used to assess the best model feature contribution.Results: A total of 565 patients were included in this study on machine learning-based models for predicting the risk of miscarriage in patients with immune-abnormal pregnancies. Twenty-eight risk warning models were developed, and the predictive model constructed using XGBoost demonstrated the best performance with an AUC of 0.9209. The SHAP analysis of the best model highlighted the total number of medications, as well as the use of aspirin and low molecular weight heparin, as significant influencing factors. The implementation of the pregnancy risk scoring rules resulted in accuracy, precision, and F1 scores of 0.3009, 0.1663, and 0.2852, respectively. The economic evaluation showed a saving of ¥7,485,865.7 due to the model.Conclusion: The predictive model developed in this study performed well in estimating the risk of miscarriage in patients with immune-abnormal pregnancies. The findings of the model interpretation identified the total number of medications and the use of other medications during pregnancy as key factors in the early warning model for miscarriage risk. This provides an important basis for early risk assessment and intervention in immune-abnormal pregnancies. The predictive model developed in this study demonstrated better risk prediction performance than the Pregnancy Risk Management System (PRMS) and also demonstrated economic value. Therefore, miscarriage risk prediction in patients with immune-abnormal pregnancies may be the most cost-effective management method.

8 September 2022 in BMJ Open
Verified
Journal Article
Open access
PDF file
XWXing-wei Wu
Xing-wei Wu
JZJia-Ying Zhang
Jia-Ying Zhang
HCHuan Chang
Huan Chang
XSXue-Wu Song
Xue-Wu Song
YWYa-Lin Wen
Ya-Lin Wen
RTRong-Sheng Tong
Rong-Sheng Tong
Objective This study aimed to develop an adverse drug reactions (ADR) antecedent prediction system using machine learning algorithms to provide the reference for security usage of Chinese herbal injections containing Panax notoginseng saponin in clinical practice. Design A nested case–control study. Setting National Center for ADR Monitoring and the Electronic Medical Record (EMR) system. Participants All patients were from five medical institutions in Sichuan Province from January 2010 to December 2018. Main outcomes/measures Data of patients with ADR who used Chinese herbal injections containing Panax notoginseng saponin were collected from the National Center for ADR Monitoring. A nested case–control study was used to randomly match patients without ADR from the EMR system by the ratio of 1:4. Eighteen machine learning algorithms were applied for the development of ADR prediction models. Area under curve (AUC), accuracy, precision, recall rate and F1 value were used to evaluate the predictive performance of the model. An ADR prediction system was established by the best model selected from the 1080 models. Results A total of 530 patients from five medical institutions were included, and 1080 ADR prediction models were developed. Among these models, the AUC of the best capable one was 0.9141 and the accuracy was 0.8947. According to the best model, a prediction system, which can provide early identification of patients at risk for the ADR of Panax notoginseng saponin, has been established. Conclusion The prediction system developed based on the machine learning model in this study had good predictive performance and potential clinical application.

8 August 2023 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
XSXuewu Song
Xuewu Song
YTYitong Tong
Yitong Tong
YLYi Luo
Yi Luo
HCHuan Chang
Huan Chang
GGGuangjie Gao
Guangjie Gao
RTRong-Sheng Tong
Rong-Sheng Tong
Background: Short-term unplanned readmission is always neglected, especially for elderly patients with coronary heart disease (CHD). However, tools to predict unplanned readmission are lacking. This study aimed to establish the most effective predictive model for the unplanned 7-day readmission in elderly CHD patients using machine learning (ML) algorithms.Methods: The detailed clinical data of elderly CHD patients were collected retrospectively. Five ML algorithms, including extreme gradient boosting (XGB), random forest, multilayer perceptron, categorical boosting, and logistic regression, were used to establish predictive models. We used the area under the receiver operating characteristic curve (AUC), accuracy, precision, recall, the F1 value, the Brier score, the area under the precision-recall curve (AUPRC), and the calibration curve to evaluate the performance of ML models. The SHapley Additive exPlanations (SHAP) value was used to interpret the best model.Results: The final study included 834 elderly CHD patients, whose average age was 73.5 ± 8.4 years, among whom 426 (51.08%) were men and 139 had 7-day unplanned readmissions. The XGB model had the best performance, exhibiting the highest AUC (0.9729), accuracy (0.9173), F1 value (0.9134), and AUPRC (0.9766). The Brier score of the XGB model was 0.08. The calibration curve of the XGB model showed good performance. The SHAP method showed that fracture, hypertension, length of stay, aspirin, and D-dimer were the most important indicators for the risk of 7-day unplanned readmissions. The top 10 variables were used to build a compact XGB, which also showed good predictive performance.Conclusions: In this study, five ML algorithms were used to predict 7-day unplanned readmissions in elderly patients with CHD. The XGB model had the best predictive performance and potential clinical application perspective.

18 November 2022 in Research Square
Verified
Preprint
Open access
PDF file
WJWu Jingxian
Wu Jingxian
CHChang Huan
Chang Huan
TRTong Rongsheng
Tong Rongsheng
XWXing-wei Wu
Xing-wei Wu
Handling missing data is indispensable in health-care real-world data processing. Imputing method may introduce error and multicollinearity. Therefore, we explored (Optimal Intact Subset Method, OIS.Method) to avoid the issues. By exploring an optimal deleting way of columns and rows with missing data, a subset retaining most information of original datasets was determined. Traditionally, we can traverse all deleting ways. But the computational cost is too high to use in large datasets. OIS.Method used an indicator to determine the optimal deleting order which can ascertain the optimal deleting way and simplify computing. In order to validate the effectiveness of OIS.Method, we compared OIS.Method with five other missing data handling methods in simulated real-world classification datasets. Additionally, we validated OIS.Method in two real-world classification tasks. In simulated datasets, the performance of OIS.Method was best(highest AUC was 1). In real-world datasets, OIS.Method could acquire better classification performance. Take AUC for an example: OIS.Method VS Simple Impute VS Random Forest VS Modified Random Forest, 0.8179±0.0005 VS 0.8116±0.0002 VS 0.8087±0.0009 VS 0.8093±0.0014 in task1, and 0.7028±0.0126 VS 0.6963±0.0231 VS 0.6957±0.0247 VS 0.6699±0.0249 in task2. The calculation of OIS.Method is smaller, and it is well-suited for large real-world datasets.